drugset / Trial / NCT03965247

Lithium Effects on Reward Processing and Reappraisal in Healthy Volunteers

NCT03965247

Completed 37 enrolled University of Oxford
RandomizedParallel-groupDouble-blindBasic science

Summary

Bipolar disorder has been associated with blunted activity in regions associated with emotional processing, such as striatal activity during reward anticipation as well as prefrontal activity during reappraisal. Lithium is the most effective treatment in bipolar disorder. Neurochemical and molecular basis of lithium is well known, but how this translates to mood stabilisation is not understood. This study is designed to address how lithium influences reward and emotion regulation processes in humans.

Timeline

Start
2011-10-31
Primary completion
2012-09-04
Completion
2012-09-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Unknown 800 mg Oral

Indications

No indication recorded.